Considering the area of intrusion or modification of myointimal cells in the muscle layer, characterized by the immunohistochemical marker HHF35 monoclonal antibody both hyperplasia with invasion in the intima (Figure 3A), and, in and hyperplasia without muscle invasion in the intima (Figure 3B) were observed. The following results were obtained: